Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological... pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCureshow more

PharmacyinUSA

26,273 subscribers

15,939 просмотров • 4 месяцев назад •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

Комментарии: 11

Фото профиля Self determination for all people.👊🏽👊🏼👊🏿

Self determination for all people.👊🏽👊🏼👊🏿4 месяцев назад

Cancer us caused by PARASITES. And IVERMECTIN kills PARASITES.

Фото профиля randall millard (blue checkmark)

randall millard (blue checkmark)4 месяцев назад

Do you put patients in touch with Dr. Makis? My neighbor is dying from multiple myoloma (sp?) in his bones. How can he contact Dr. Makis for a protocal for his specific cancer?

Фото профиля Jeffrey

Jeffrey4 месяцев назад

Involving oneself with Alex Jones WILL NOT help the cause. He's a freakish, lying scumbag and should be avoided like the plague.

Фото профиля Per Bondesen

Per Bondesen4 месяцев назад

Rapidly dividing cells have ) in common a high contents of iron to enable the division. Presumably the iron that attracts the Ivermectin which in turn destroys the cancerous cells. That is at least the mechanism of cancer destruction achieved by Artemisia Annua (Dr Henry Lai).

Фото профиля SaltyBeaner

SaltyBeaner4 месяцев назад

😅😂🤣😂😅😆😅😂🤣😂😅😆😅😂🤣FUCK @RealAlexJones flip flopping fat drama queen SOB.

Фото профиля ♫☺ Dr Karel Vreeburg☺♪

♫☺ Dr Karel Vreeburg☺♪4 месяцев назад

Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort

Фото профиля NIASCEND | Dr. Dmitry Kats

NIASCEND | Dr. Dmitry Kats4 месяцев назад

They can call it the “mRNA vaccine” they hate so much too now…

Фото профиля daddy war blox

daddy war blox4 месяцев назад

Sweet wormwood was outlawed in some countries before and since the Industrial Revolution

Фото профиля PharmacyinUSA

PharmacyinUSA4 месяцев назад

Interesting 🧐

Фото профиля MrBBBBenny

MrBBBBenny4 месяцев назад

Is the image on the right that Alex James Blur bloke on the left after he's snorted a line of the horse worm drug? Looks a tad peaky.

Фото профиля Siela

Siela4 месяцев назад

Cancers, MS and other diseases and viruses too are probably all parasites. Most of them microscopic. 🔬

Похожие видео

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer • Colon cancer • Lung cancer • Leukemia • Liver cancer • Stomach cancer Why scientists are interested: ✅ Studies suggest Ivermectin may trigger apoptosis, also known as programmed cancer cell death ✅ Researchers are investigating how it may affect tumor growth pathways and cancer stem-like cells ✅ Some preclinical studies are exploring Ivermectin alongside chemotherapy in laboratory models And THAT is why repurposed medicine conversations have exploded across podcasts, TikTok, X, and cancer forums worldwide. Not because the science is settled. Because people are shocked that a low-cost anti-parasitic drug is even being discussed in cancer research at all. But whether critics like it or not… The public conversation around repurposed drugs is getting impossible to ignore.

Joe Tippens

10,621 просмотров • 4 месяцев назад

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 просмотров • 3 месяцев назад

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 просмотров • 2 месяцев назад

🚨 “THIS WAS NEVER MEANT TO BE SEEN.” In a viral interview, William Makis says cancer research may have overlooked something big. Repurposed antiparasitics are getting serious attention. Here’s what he points to 👇 • Ivermectin may target cancer stem cells that chemo struggles to reach. • Fenbendazole and Mebendazole may interfere with tumor energy pathways. • Drug resistance could potentially be reduced. • Tumor shrinkage has been reported in difficult cases. The conversation around Anti-parasitic medicines is growing fast and patients need to know more. Follow us because we provide this type of information everyday! Visit our profile PharmacyinUSA to find these meds 🙌🏻 #Ivermectin #Fenbendazole #Mebendazole #Cancercure #MakisMD #PharmacyinUSA

PharmacyinUSA

20,889 просмотров • 6 месяцев назад

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness

🚨 “THIS WAS NEVER SUPPOSED TO GO PUBLIC.” In a viral interview, William Makis claims cancer research missed something massive. But repurposed antiparasitics are hiding in plain sight. He says 👇 • Ivermectin targets cancer stem cells, chemo doesn’t touch • Fenbendazole and mebendazole disrupt tumor fuel pathways • Resistance may be reversed • Tumor shrinkage observed where nothing else worked Once you understand why these drugs are being studied, the next question is obvious. Where do you even get a clean, reliable supply? That’s why many independent researchers choose GENIX MEDS for ivermectin, fenbendazole, and mebendazole. Straightforward access. Affordable pricing. Worldwide delivery. #Ivermectin #Makismd #Cancercure #CancerAwareness

GENIX MEDS

244,318 просмотров • 8 месяцев назад

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

🚨 IVERMECTIN AND CANCER: WHAT THE RESEARCH ACTUALLY SHOWS A researcher recently shared what they found after looking into Ivermectin and cancer. They discovered over 300 peer-reviewed papers on PubMed examining Ivermectin in cancer. While most of this research is preclinical (cell lines, mice, and rats), the body of work is extensive and covers many different mechanisms. Key points from the research include: ✅ Ivermectin appears to target cancer stem cells, which standard chemotherapy often does not effectively kill. ✅ It can help reverse multi-drug resistance in cancer cells and may sensitise them to chemotherapy. ✅ It acts as a radio sensitizer, potentially making cancer cells more responsive to radiation. ✅ It can inhibit angiogenesis, limiting the tumor’s ability to form new blood vessels. ✅ It may inhibit enzymes involved in cancer cell detachment and spread, reducing the potential for metastasis. The researcher noted that Ivermectin is an off-patent, low-cost drug. Because of this, there has been little financial incentive to fund large-scale human trials in oncology, which is why most of the data remains preclinical.

Joe Tippens

20,524 просмотров • 2 месяцев назад

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

🚨 DR WILLIAM MAKIS: “THE CANCER BREAKTHROUGH THEY DON’T WANT TO TALK ABOUT” Oncologist Dr William Makis dropped a bombshell on The Shannon Joy Show — revealing what decades of cancer research have missed. “Antiparasitics have a dozen mechanisms of action… ivermectin goes after cancer stem cells… fenbendazole and mebendazole shut down glucose transporters — starving the tumor of fuel.” According to Dr Makis, chemo alone kills only the rapidly dividing cells — leaving cancer stem cells alive to spread years later. But add ivermectin, he says, and those hidden cells are targeted too — reversing resistance and triggering “tumor shrinkage oncologists have never seen.” 400+ studies now explore ivermectin’s potential role in cancer treatment — yet mainstream medicine remains silent. Could cheap, repurposed antiparasitics threaten the trillion-dollar cancer industry? Dr Makis thinks so. And he’s not backing down. Shannon Joy

Commentary | Global Ivermectin Research Hub

2,324,509 просмотров • 11 месяцев назад

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

TheSkyMeds | Cancer & Parasites Explained

5,144,279 просмотров • 1 год назад

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

12,063 просмотров • 2 месяцев назад

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 просмотров • 3 месяцев назад

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,308 просмотров • 3 месяцев назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 просмотров • 1 год назад

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 просмотров • 2 лет назад

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 просмотров • 1 год назад

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but NOT the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

Jan Jekielek

96,002 просмотров • 1 год назад

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

117,774 просмотров • 1 год назад

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

PharmacyinUSA

14,784 просмотров • 3 месяцев назад

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and patient outcomes. 💊 WHERE DOES MAKIS START? Makis says the Ivermectin dose he discusses for intermediate to high-grade cancers starts around: 📌 1 mg/kg/day For lower-grade cancers, he says he starts lower, around: 📌 0.5 mg/kg/day He gives examples including CLL and multiple myeloma. 📅 WHY DOES HE TALK ABOUT 3 MONTHS? Makis says he suggests assessing Ivermectin use over approximately 3 months, followed by reassessment using: 🧪 Blood work 📊 Cancer markers 🩻 Follow-up imaging According to him, some changes in cancer markers can appear within 3–4 weeks. He specifically mentions: • PSA • CEA • CA-125 🩻 THEN COMES THE IMAGING Makis says tumor activity may begin changing on a PET scan in about a month. But physically seeing tumors or lymph nodes shrink can take longer. He says changes may begin appearing on: MRI → PET-CT → CT over approximately 2–3 months. 👀 THEN CAMPBELL ASKS ABOUT HIS MOST DRAMATIC RESULTS Makis' answer is the part that stands out: “The best results I’ve seen in my patients are patients who are doing a combination of chemotherapy and ivermectin.” 🔥 IVERMECTIN IS THE DETAIL THAT STANDS OUT. Makis says the best results he's seen have involved patients using Ivermectin alongside chemotherapy. That makes the question even more interesting: "Could Ivermectin have a larger role in cancer research than we currently understand?" ❓ THE BIGGER REPURPOSED-MEDICINE QUESTION This conversation puts Ivermectin + chemotherapy into a much bigger discussion about drug repurposing in cancer. What makes repurposed medicines so interesting? 💊 Existing medicines 🧬 Multiple biological pathways 🔬 New applications being investigated 📊 Different cancer types ⚡ Potential combination strategies And Ivermectin isn't the only repurposed medicine attracting attention. Fenbendazole. Mebendazole. Metformin. Doxycycline. Statins. Different medicines. Different mechanisms. But one common question: Could medicines we already have be hiding new possibilities in cancer research? THAT'S THE CONVERSATION WORTH WATCHING. 📌 SAVE this discussion for the next repurposed-medicine breakdown. 🔄️ REPOST if you think existing medicines deserve a second look in cancer research. 💊 Looking for Ivermectin or other repurposed medicines? Explore available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Chemotherapy #Cancer #DrWilliamMakis #DrJohnCampbell #RepurposedMedicine #MedicalResearch

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and patient outcomes. 💊 WHERE DOES MAKIS START? Makis says the Ivermectin dose he discusses for intermediate to high-grade cancers starts around: 📌 1 mg/kg/day For lower-grade cancers, he says he starts lower, around: 📌 0.5 mg/kg/day He gives examples including CLL and multiple myeloma. 📅 WHY DOES HE TALK ABOUT 3 MONTHS? Makis says he suggests assessing Ivermectin use over approximately 3 months, followed by reassessment using: 🧪 Blood work 📊 Cancer markers 🩻 Follow-up imaging According to him, some changes in cancer markers can appear within 3–4 weeks. He specifically mentions: • PSA • CEA • CA-125 🩻 THEN COMES THE IMAGING Makis says tumor activity may begin changing on a PET scan in about a month. But physically seeing tumors or lymph nodes shrink can take longer. He says changes may begin appearing on: MRI → PET-CT → CT over approximately 2–3 months. 👀 THEN CAMPBELL ASKS ABOUT HIS MOST DRAMATIC RESULTS Makis' answer is the part that stands out: “The best results I’ve seen in my patients are patients who are doing a combination of chemotherapy and ivermectin.” 🔥 IVERMECTIN IS THE DETAIL THAT STANDS OUT. Makis says the best results he's seen have involved patients using Ivermectin alongside chemotherapy. That makes the question even more interesting: "Could Ivermectin have a larger role in cancer research than we currently understand?" ❓ THE BIGGER REPURPOSED-MEDICINE QUESTION This conversation puts Ivermectin + chemotherapy into a much bigger discussion about drug repurposing in cancer. What makes repurposed medicines so interesting? 💊 Existing medicines 🧬 Multiple biological pathways 🔬 New applications being investigated 📊 Different cancer types ⚡ Potential combination strategies And Ivermectin isn't the only repurposed medicine attracting attention. Fenbendazole. Mebendazole. Metformin. Doxycycline. Statins. Different medicines. Different mechanisms. But one common question: Could medicines we already have be hiding new possibilities in cancer research? THAT'S THE CONVERSATION WORTH WATCHING. 📌 SAVE this discussion for the next repurposed-medicine breakdown. 🔄️ REPOST if you think existing medicines deserve a second look in cancer research. 💊 Looking for Ivermectin or other repurposed medicines? Explore available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Chemotherapy #Cancer #DrWilliamMakis #DrJohnCampbell #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

25,194 просмотров • 21 дней назад

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA

PharmacyinUSA

136,645 просмотров • 13 дней назад

🚨 Ivermectin for Cancer: The Important Part Most People Miss Ivermectin is being explored for its potential anti-cancer effects; it can disrupt cancer cell mitochondria, interfere with glucose metabolism, and help reactivate apoptosis (the cell’s natural self-destruct system). But here’s what often gets overlooked: Ivermectin can also place extra demand on your body’s detoxification pathways. Supporting your terrain while using it is essential. Here’s how this person supports their body during use: Liposomal glutathione + NAC for liver and mitochondrial support Binders like activated charcoal and fulvic acid to help with detoxification Cycling protocol: 5 days on, 2 days off As they put it: “Ivermectin may help starve the tumor, but don’t starve your terrain in the process.” This approach combines the potential benefits with practical ways to protect overall health. Follow me for more updates.

🚨 Ivermectin for Cancer: The Important Part Most People Miss Ivermectin is being explored for its potential anti-cancer effects; it can disrupt cancer cell mitochondria, interfere with glucose metabolism, and help reactivate apoptosis (the cell’s natural self-destruct system). But here’s what often gets overlooked: Ivermectin can also place extra demand on your body’s detoxification pathways. Supporting your terrain while using it is essential. Here’s how this person supports their body during use: Liposomal glutathione + NAC for liver and mitochondrial support Binders like activated charcoal and fulvic acid to help with detoxification Cycling protocol: 5 days on, 2 days off As they put it: “Ivermectin may help starve the tumor, but don’t starve your terrain in the process.” This approach combines the potential benefits with practical ways to protect overall health. Follow me for more updates.

Dr. Zakaria MD

14,209 просмотров • 2 месяцев назад